Dr. Riley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
529 S Jackson St
Louisville, KY 40202Phone+1 502-562-4358Fax+1 502-562-6811
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2009
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2002 - 2005
- University of Louisville School of MedicineClass of 2002
Certifications & Licensure
- KY State Medical License 2010 - 2025
- MA State Medical License 2004 - 2010
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer. Start of enrollment: 2009 Mar 01
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsDopaminergic control of anxiety in young and aged zebrafishVictoria Kacprzak, Neil A. Patel, Elizabeth Riley, Lili Yu, Jing-Ruey J. Yeh
Pharmacology, Biochemistry, and Behavior. 2017-06-01 - 2 citationsFinal Analysis of a Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early Stage Breast Cancer.Leonid B. Reshko, Jianmin Pan, Shesh N. Rai, Nicolas Ajkay, A.E. Dragun
International Journal of Radiation Oncology, Biology, Physics. 2021-06-25 - 6 citationsPACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Horm...Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma Mahtani, Cynthia Ma
Journal of Clinical Oncology. 2024-06-10
Press Mentions
- Top Doctors 2019August 3rd, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: